Skip to main content

Table 1 Characteristics of study participants

From: Association of 25-hydroxyvitamin D levels with lipid profiles in osteoporosis patients: a retrospective cross-sectional study

Variables

(N) Mean (SD) Median (Q1–Q3)a

25(OH)D level continuous, ng/mL

(2063) 21.13 (8.83) 20.00 (15.00–25.83)

TC, mmol/L

(1566) 4.56 (1.00) 4.53 (3.89–5.16)

TG, mmol/L

(1566) 1.36 (0.88) 1.13 (0.82–1.65)

LDL, mmol/L

(1566) 2.71 (0.79) 2.66 (2.16–3.21)

HDL, mmol/L

(1566) 1.47 (0.33) 1.43 (1.23–1.66)

APO-A, g/L

(1566) 1.37 (0.27) 1.34 (1.18–1.53)

APO-B, g/L

(1566) 0.89 (0.23) 0.88 (0.73–1.04)

LPa, mg/L

(1566) 186.17 (166.01) 131.00 (73.25–243.00)

HCY, umol/L

(1567) 12.97 (6.37) 11.36 (9.27–15.04)

Ca, mmol/L

(2029) 2.26 (0.17) 2.26 (2.17–2.35)

β-CTX, ng/mL

(2045) 0.42 (0.30) 0.34 (0.19–0.59)

P1NP, ug/L

(2044) 50.44 (34.64) 43.00 (29.00–64.00)

Sex, N (%)

 Male

333 (16.14%)

 Female

1730 (83.86%)

Age (years)

(2063) 68.51 (8.66) 68.00 (63.00–74.00)

Age (years), N (%)

 > 50, ≤ 70

1256 (60.88%)

 > 70

807 (39.12%)

BMI (kg/m2), N (%)

 ≤ 18.5

99 (4.80%)

 > 18.5, ≤ 23.9

1255 (60.83%)

 > 23.9, ≤ 28

556 (26.95%)

 > 28, ≤ 35

147 (7.13%)

 > 35

6 (0.29%)

Season of blood collection, N (%)

 Spring (March, April and May)

503 (24.38%)

 Summer (June, July and August)

509 (24.67%)

 Autumn (September, October and November)

608 (29.47%)

 Winter (December, January and February)

443 (21.47%)

Year of blood collection, N (%)

 2015

21 (1.02%)

 2016

32 (1.55%)

 2017

48 (2.33%)

 2018

128 (6.20%)

 2019

458 (22.20%)

 2020

578 (28.02%)

 2021

705 (34.17%)

 2022

93 (4.51%)

Hypertension, N (%)

 No

1420 (68.83%)

 Yes

643 (31.17%)

Diabetes, N (%)

 No

1772 (85.89%)

 Yes

291 (14.11%)

Main diagnosis, N (%)

 OP without fractures

1391 (67.43%)

 OPF

672 (32.57%)

  1. SD standard deviation, Q1 first quartile, Q3 third quartile, CI confidence interval, 25(OH)D 25-hydroxy vitamin D, TC total cholesterol, TG triglyceride, HDL high-density lipoprotein, LDL low-density lipoprotein, APO-A apolipoproteina, APO-B apolipoproteinb, LPa lipoproteina, HCY homocysteine, Ca calcium, BMI body mass index, β-CTX beta-C-terminal telopeptide of type I collagen, P1NP procollagen type I N-terminal propeptide, OP osteoporosis, OPF osteoporotic fracture
  2. aFor continuous variables